Chicago Tribune: Artist Riva Lehrer paints portraits of people with disabilities
UC alumna is a leading activist of disability culture
University of Cincinnati alumna Riva Lehrer is an artist, writer and curator whose work focuses on issues of physical identity and the socially challenged body, especially in explorations of cultural depictions of disability.
Lehrer fell in love with portraiture as a student at UC, where she studied fine/studio arts in the College of Design, Architecture, Art, and Planning. She came to recognize “a mutual transformation” at work in every portrait.
“When I am in a museum and read the tags next to a work," she told the Chicago Tribune, "I wonder about the relationship between artist and subject, and usually there is little of that history explained — what it was like between them, what it was like to sit for them — and based on my experience, the real product of a portrait is always that relationship.”
Lehrer, who has spina bifida, now paints portraits of others with disabilities would "the mock heroics, the 'freak show’ or the toxic staring."
Read more about her work in the Tribune and Yahoo News.
Featured image at top: Portrait artist and author Riva Lehrer photographed on the roof of her home in Chicago on Feb. 19, 2021. Photo/Chris Sweda/Chicago Tribune
Related Stories
A&S alumni spotlight: Deborah Hampton
April 7, 2025
Deborah Hampton shares how UC and A&S have made an indelible mark on her life.
CPS student athletes put their skills to the test in Fifth Third...
April 7, 2025
Cincinnati media cover the fourth annual CPS All-Star Showcase event held Sunday, April 6 in Fifth Third Arena. The University of Cincinnati partnered with Cincinnati Public Schools to showcase the talent of student athletes and help assist homeless families in the school district.
ChemoID test leads to better outcomes in platinum-resistant...
April 7, 2025
MSN and MSN UK highlighted results from a new Phase 3 trial published in the journal npj Precision Oncology that found a cancer stem cell test can accurately choose more effective treatments and lead to improved outcomes for patients with platinum-resistant ovarian cancer.